You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
| Title |
Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine
|
|---|---|
| Published in |
medRxiv, July 2021
|
| DOI | 10.1101/2021.07.28.21261159 |
| Authors |
Stephen J. Thomas, Edson D. Moreira, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L. Perez, Gonzalo Pérez Marc, Fernando P. Polack, Cristiano Zerbini, Ruth Bailey, Kena A. Swanson, Xia Xu, Satrajit Roychoudhury, Kenneth Koury, Salim Bouguermouh, Warren V. Kalina, David Cooper, Robert W. Frenck, Laura L. Hammitt, Özlem Türeci, Haylene Nell, Axel Schaefer, Serhat Ünal, Qi Yang, Paul Liberator, Dina B. Tresnan, Susan Mather, Philip R. Dormitzer, Uğur Şahin, William C. Gruber, Kathrin U. Jansen, C4591001 Clinical Trial Group |
X Demographics
The data shown below were collected from the profiles of 17,541 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1774 | 10% |
| United States | 1236 | 7% |
| France | 484 | 3% |
| United Kingdom | 361 | 2% |
| Germany | 354 | 2% |
| Turkey | 274 | 2% |
| Canada | 199 | 1% |
| Brazil | 194 | 1% |
| Italy | 151 | <1% |
| Other | 1381 | 8% |
| Unknown | 11133 | 63% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 16559 | 94% |
| Scientists | 490 | 3% |
| Practitioners (doctors, other healthcare professionals) | 343 | 2% |
| Science communicators (journalists, bloggers, editors) | 121 | <1% |
| Unknown | 28 | <1% |